Kentucky Retirement Systems Sells 189 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Kentucky Retirement Systems cut its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 1.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,683 shares of the medical device company’s stock after selling 189 shares during the quarter. Kentucky Retirement Systems’ holdings in Cooper Companies were worth $1,258,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of COO. Ashton Thomas Securities LLC acquired a new position in Cooper Companies during the third quarter valued at approximately $25,000. Covestor Ltd boosted its position in shares of Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares in the last quarter. Byrne Asset Management LLC bought a new stake in shares of Cooper Companies in the 4th quarter valued at $33,000. Brown Brothers Harriman & Co. raised its stake in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after buying an additional 275 shares during the period. Finally, West Financial Advisors LLC bought a new position in Cooper Companies during the fourth quarter worth about $49,000. 24.39% of the stock is owned by institutional investors.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $88.48 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The business has a 50-day moving average of $92.94 and a 200-day moving average of $99.66. The stock has a market capitalization of $17.66 billion, a price-to-earnings ratio of 45.37, a PEG ratio of 2.25 and a beta of 1.00. The Cooper Companies, Inc. has a fifty-two week low of $84.76 and a fifty-two week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the firm posted $0.87 EPS. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have issued reports on COO. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Wells Fargo & Company lifted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley dropped their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Finally, Citigroup cut their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.